AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Univ8 Genomics at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Univ8 Genomics brings 1 presentation to AMP 2026 in Seattle. Its session covers automated, integrated genomic profiling of blood cancers. The company makes targeted NGS assays for leukaemia, lymphoma and myeloid cancers that detect clonality, translocations, copy number changes and mutations in one test.

OrganizationAMP 2026 Attendance
Univ8 Genomics
Belfast, UK
Diagnostics
Makes targeted NGS assays for leukaemia, lymphoma and myeloid cancers that detect clonality, translocations, copy number changes and mutations in one test.
Workshop
Wed, Nov 11
11:00am–11:50am
Automated and Integrated Genomic Profiling of Hematologic Malignancies
Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run.
Workshop hosted by Roche Diagnostics

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Univ8 Genomics

Tell us what you sell and we’ll find the people at Univ8 Genomics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction